Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas

Apoptosis

Volumn 12, Issue 4, 2007, Pages 695-705

  Konstantinidou, A E ^a   Givalos, N ^a   Gakiopoulou, H ^a   Korkolopoulou, P ^a   Kotsiakis, X ^b   Boviatsis, E ^c   Agrogiannis, G ^a   Mahera, H ^d   Patsouris, E ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b General Hospital of Hania   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d KAT HOSPITAL   (Greece)

Author keywords

Active caspase 3; Apoptosis; ASP175; bcl 2; CPP32; Disease free survival; Ki 67; Meningioma; Mitosin C; PCNA; Prognosis; Proliferation; Recurrence; ss DNA; Topoisomerase IIa

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; CASPASE 3; CYCLINE; DNA TOPOISOMERASE (ATP HYDROLYSING); ESTROGEN; KI 67 ANTIGEN; MITOMYCIN C; MONOCLONAL ANTIBODY; PROGESTERONE; PROTEIN BCL 2; SINGLE STRANDED DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; DISEASE COURSE; DISEASE FREE SURVIVAL; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME RELEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MITOSIS INDEX; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STANDARD; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE; UNIVARIATE ANALYSIS;

AGED; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CASPASE 3; ENZYME PRECURSORS; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECEPTORS, STEROID; SURVIVAL RATE;

EID: 33947103476     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-0001-4     Document Type: Article

References (42)

1. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system, 2nd edn. International Agency for Research, Lyon, pp 176-184
2. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM (1993) Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 33:955-963
3. McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF (1993) Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 23:349-353
4. Ng HK, Chen L (1998) Apoptosis is associated with atypical or malignant change in meningiomas. An in situ labelling and immunohistochemical study. Histopathology 33:64-70
5. Konstantinidou AE, Korkolopoulou P, Patsouris E et al (2001) Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas. J Neuro-Oncol 55:1-9
6. Abramovich CM, Prayson RA (2000) Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome. Am J Clin Pathol 114:84-92
7. Weisberg S, Ashkenazi E, Israel Z, Attia M, Shoshan Y, Umansky F, Brodie C (2001) Anaplastic and atypical meningiomas express high levels of Fas and undergo apoptosis in response to Fas ligation. Am J Pathol 159:1193-1197
8. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-1098
9. Konstantinidou AE, Korkolopoulou P, Patsouris E (2002) Apoptotic markers for tumor recurrence: a minireview. Apoptosis 7:461-470
10. Nicholson DW (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6:1028-1042
11. Kumar S (1999) Mechanisms mediating caspase activation in cell death. Cell Death Differ 6:1060-1066
12. Porter AG, Janicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6:99-104
13. Reed JC (2000) Mechanisms of apoptosis. Am J Pathol 157:1415-1430
14. Woo M, Hakem R, Seongas MS et al (1998) Essential contribution of caspase3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12:806-819
15. Tian R, Zhang GY, Yan CH, Dai YR (2000) Involvement of poly (ADP-ribose) polymerase and activation of caspase-3-like protease in heat shock-induced apoptosis in tobacco suspension cells. FEBS Lett 474:11-15
16. Rami A, Jansen S, Giesser I, Winckler J (2002) Post-ischemic activation of caspase-3 in the rat hippocampus: evidence of an axonal and dendritic localisation. Neurochem Int 43:211-223
17. Kuida K, Zheng TS, Na S et al (1996) Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372
18. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39
19. O'Neil AJ, Boran SA, O'Keane C et al (2001) Caspase-3 expression in benign prostatic hyperplasia and prostate carcinoma. The Prostate 47:183-188
20. Konstantinidou AE, Pavlopoulos PM, Patsouris E, Kaklamanis L, Davaris P (1998) Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186:325-330
21. Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabailk A, Gascoyne R, Reed JC (1997) Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase 3), a cell death protease. Cancer Res 57:1605-1613
22. Konstantinidou AE, Patsouris E, Korkolopoulou P et al (2001) DNA topoisomerase IIα expression correlates with cell proliferation but not with recurrence in intracranial meningiomas. Histopathology 39:402-408
23. Konstantinidou AE, Korkolopoulou P, Kavantzas N et al (2003) Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas. Histol Histopathol 18:67-74
24. Konstantinidou AE, Korkolopoulou P, Mahera H et al (2003) Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival. Histopathology 43:280-290
25. Yu SW, Wang H, Poitras MF et al (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297:259-263
26. Wilhelm S, Wagner H, Hacker G (1998) Activation of caspase-3-like enzymes in non-apoptotic T cells. Eur J Immunol 28:891-900
27. Salvesen GS, Duckett CS (2002) IAP protein: blocking the road to deaths door. Nat Rev Mol Cell Biol 3:401-410
28. Zhao H, Yenari MA, Cheng D, Sapolsky RM, Steinberg GK (2003) Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 85:1026-1036
29. Rudner J, Jendrossek V, Belka C (2002) New insights in the role of Bcl-2. Bcl-2 and the endoplasmic reticulum. Apoptosis 7:441-447
30. Fujita N, Tsuruo T (1998) Involvement of bcl-2 cleavage in the acceleration of VP-16-induced U937 cell apoptosis. Biochem Biophys Res Commun 246:484-488
31. Clem RJ, Cheng EH, Karp CL et al (1998) Modulation of cell death by Bcl-Xl through caspase interaction. Proc Natl Acad Sci USA 95:554-559
32. Arai M, Sasaki A, Saito N, Nakazato Y (2005) Immunohistochemical analysis of cleaved caspase-3 detects high levels of apoptosis frequently in diffuse large B-cell lymphomas of the central nervous system. Pathol Intern 55:122-129
33. Ellison DW, Steart PV, Gatter KC, Weller RO (1995) Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 21:352-361
34. Pfister Y, Savioz A, Vallet PG, Dubois-Dauphin M (2003) Permanent cerebral ischemia induces sustained procaspase 9L increase not controlled by Bcl-2. Brain Res 966:26-39
35. Frankfurt OS, Robb JA, Sugarbaker EV, Villa L (1997) Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA. Relation to bcl-2 expression, hormone receptors and lymph node metastases. Clin Cancer Res 3:465-471
36. Vakkala M, Pääkkö P, Soini Y (1999) Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer 81:592-599
37. Hellemans P, van Dam PA, Wexler J, van Oosterom AT, Buytaert P, van Marck E (1995) Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 72:354-360
38. Mosnier JF, Gentil Perret A, Brunon J, Boucheron S (1996) Expression of the bcl-2 oncoprotein in meningiomas. Am J Clin Pathol 106:652-659
39. Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70:183-202
40. Ragel BT, Jensen RL (2005) Molecular genetics of meningiomas. Neurosurg Focus 19:E9
41. Konstantinidou AE, Korkolopoulou P, Patsouris E (2005) Apoptotic markers for primary brain tumor prognosis. J Neurooncol 72:151-156
42. Jonges LE, Nagelkerke JF, Ensink NG et al (2001) Caspase-3 activity as a prognostic factor in colorectal carcinoma. Lab Invest 81:681-688